Leaders
Shares of Cool Holdings Inc (NASDAQ:AWSM) announced it was buying the Simply Mac chain of Apple Inc (NASDAQ:AAPL) retail and repair stores. Simply Mac is the largest Apple Premier Partner in the US, with 43 stores in 18 states.
The stock jumped nearly 21% to $2.80.
Cars.com Inc (NYSE:CARS) had first-quarter earnings that came in ahead of Street expectations Friday morning as brand awareness hit an all-time high. The online vehicle marketplace saw adjusted net income fall 27% to $20.7 million, or $0.31 per share. That crushed analyst expectations of $0.04 per share.
Shares sped ahead 4.5% to $21.76.
Creative Realities Inc (NASDAQ:CREX), a digital marketing company, posted first-quarter revenue late Wednesday that more than doubled year over year. The company brought in revenue of $9.5 million, up from $4.1 million a year ago.
The stock climbed nearly 10% to $2.62.
READ: Buds & Duds: Cannabis stocks flat on Friday; Next Green Wave shares surge
Westport Fuel systems Inc (NASDAQ:WPRT), the manufacturer of clean fuel systems, reported first-quarter results that came in ahead of expectations, and won an analyst upgrade as a result.
Shares fueled up 22% to $2.04.
Laggards
Jumia Technologies AG (NYSE:JMIA) shares sank after Citron Research’s Andrew Left, a noted short seller, alleged in a report that it has the “smoking gun” that shows why Jumia equity is “worthless.”
The stock plunged 24% to $20.29.
Robotic surgery company TransEnterix Inc (NYSEAMERICAN:TRXC) dropped in response to the company's rough first-quarter earnings report late Thursday. The company missed Wall Street's consensus estimate for its EPS by 10% and whiffed on revenue by a staggering 62% for the period.
Shares collapsed 38% to $1.30.
Puma Biotechnology Inc (NASDAQ:PBYI) plunged on Friday after the company revealed that more patients than expected were discontinuing treatment with its breast cancer drug, Nerlynx, spurring a sharp drop in sales and prompting several analysts to downgrade the company's stock.
The stock plummeted 37% to $18.78.
Melinta Therapeutics Inc (NASDAQ:MLNT) on Thursday reported a loss of $26.5 million in its first quarter. On a per-share basis, the New Haven, Connecticut-based company said it had a loss of $2.34. The drugmaker posted revenue of $14.1 million in the period.
The share price swooned 25% to $3.44.
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel